[1] [1] REN Yanming, HUANG Zongyao, ZHOU Lingling, et al. Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas[J]. Nature Communications, 2023, 14(1): 1028. doi: 10.1038/s41467-023-36707-6.

[2] [2] BARTHEL L, HADAMITZKY M, DAMMANN P, et al. Glioma: molecular signature and crossroads with tumor microenvironment[J]. Cancer Metastasis Reviews, 2022, 41(1): 53-75. doi: 10.1007/s10555-021-09997-9.

[3] [3] WEI W, SHIN Y S, XUE M, et al. Single-cell phosphoproteomics resolves adaptive signaling dynamics and informs targeted combination therapy in glioblastoma[J]. Cancer Cell, 2016, 29(4): 563-573. doi: 10.1016/j.ccell.2016.03.012.

[4] [4] RATLIFF M, KARIMIAN-JAZI K, HOFFMANN D C, et al. Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression[J]. Neuro Oncology, 2023, 25(12): 2150-2162. doi: 10.1093/neuonc/noad109.

[5] [5] VERBURG N, DE WITT-HAMER P C. State-of-the-art imaging for glioma surgery[J]. Neurosurg Rev, 2021, 44(3): 1331-1343. doi: 10.1007/s10143-020-01337-9.

[6] [6] MICHELETTI C, BONETTI G, MADEO G, et al. Omics sciences and precision medicine in glioblastoma[J]. Clinica Terapeutica, 2023, 174(6): 77-84. doi: 10.7417/ct.2023.2474.

[7] [7] SCHREGEL K, HEINZ L, HUNGER J, et al. A cellular ground truth to develop MRI signatures in glioma models by correlative light sheet microscopy and Atlas-based coregistration[J]. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience, 2023, 43(30): 5574-5587. doi: 10.1523/JNEUROSCI.1470-22.2023.

[8] [8] ABRIGO J M, FOUNTAIN D M, PROVENZALE J M, et al. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation[J]. The Cochrane Database of Systematic Reviews, 2018, 1(1): CD011551. doi: 10.1002/14651858. CD011551.pub2.

[9] [9] TAKAMI H, GRAFFEO C S, PERRY A, et al. Roles of tumor markers in central nervous system germ cell tumors revisited with histopathology-proven cases in a large international cohort[J]. Cancers, 2022, 14(4): 979. doi: 10.3390/cancers14040979.

[10] [10] JIANG Yu, YANG Jinlong, LIANG Ruichao, et al. Single-cell RNA sequencing highlights intratumor heterogeneity and intercellular network featured in adamantinomatous craniopharyngioma[J]. Science Advances, 2023, 9(15): eadc8933. doi: 10.1126/sciadv.adc8933.

[11] [11] KUCHERYAVENKO A S, CHERNOMYRDIN N V, GAVDUSH A A, et al. Terahertz dielectric spectroscopy and solid immersion microscopy of ex vivo glioma model 101.8: brain tissue heterogeneity[J]. Biomedical Optics Express, 2021, 12(8): 5272-5289. doi: 10.1364/boe.432758.

[12] [12] YAMAGUCHI S, FUKUSHI Y, KUBOTA O, et al. Brain tumor imaging of rat fresh tissue using terahertz spectroscopy[J]. Scientific Reports, 2016(6): 30124. doi: 10.1038/srep30124.

[13] [13] JI Y B, OH S J, KANG S G, et al. Terahertz reflectometry imaging for low and high grade gliomas[J]. Scientific Reports, 2016(6): 36040. doi: 10.1038/srep36040.

[14] [14] MU Ning, YANG Chuanyan, XU Degang, et al. Molecular pathological recognition of freshly excised human glioma using terahertz ATR spectroscopy[J]. Biomedical Optics Express, 2022, 13(1): 222-236. doi: 10.1364/boe.445111.

[15] [15] WU Xianhao, TAO Rui, ZHANG Tianyao, et al. Biomedical applications of terahertz spectra in clinical and molecular pathology of human glioma[J]. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2023(285): 121933. doi: 10.1016/j.saa.2022.121933.

[16] [16] NIKITKINA A I, BIKMULINA P Y, GAFAROVA E R, et al. Terahertz radiation and the skin: a review[J]. Journal of Biomedical Optics, 2021, 26(4): 043005. doi: 10.1117/1. Jbo.26.4.043005.

[17] [17] WU Limin, XU Degang, WANG Yuye, et al. Study of in vivo brain glioma in a mouse model using continuous-wave terahertz reflection imaging[J]. Biomedical Optics Express, 2019, 10(8): 3953-3962. doi: 10.1364/boe.10.003953.

[20] [20] WU Limin, WANG Yuye, LIAO Bin, et al. Temperature dependent terahertz spectroscopy and imaging of orthotopic brain gliomas in mouse models[J]. Biomedical Optics Express, 2022, 13(1): 93-104. doi: 10.1364/boe.445597.

[21] [21] ZHANG Jiale, ZHANG Jie, QIU Wenjin, et al. MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma[J]. Journal of Neuro-Oncology, 2018, 139(3): 547-562. doi: 10.1007/s11060-018-2903-8.

[22] [22] RODRIGUEZ S M B, KAMEL A, CIUBOTARU G V, et al. An overview of EGFR mechanisms and their implications in targeted therapies for glioblastoma[J]. International Journal of Molecular Sciences, 2023, 24(13): 11110. doi: 10.3390/ijms241311110.

[23] [23] AN Z Y, AKSOY O, ZHENG T N, et al. Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies[J]. Oncogene, 2018, 37(12): 1561-1575. doi: 10.1038/s41388-017-0045-7.

[24] [24] NI Jiaying, ZHANG Hongjian, YANG Qing, et al. Machine-learning and radiomics-based preoperative prediction of Ki-67 expression in glioma using MRI data[J]. Academic Radiology, 2024, 31(8): 3397-3405. doi: 10.1016/j.acra.2024.02.009.

[26] [26] ZHAN Xinyu, LIU Yu, CHEN Zhiguo, et al. Revolutionary approaches for cancer diagnosis by terahertz-based spectroscopy and imaging[J]. Talanta, 2023(259): 124483. doi: 10.1016/j.talanta.2023.124483.